Mayur Ramesh

11PUBLICATIONS
57CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 22, 2026
Clinical Experience with Oral Fecal Microbiota Spores (Vowst®) in a Health System Specialty Pharmacy.

|Sep 17, 2026
Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.

|Jul 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Kevin C Ma, Diya Surie, Yuwei Zhu

|Apr 08, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024.

Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary

|Nov 28, 2024
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

Nathaniel M Lewis, Elizabeth J Harker, Lauren B Grant

|May 03, 2024
Impact of time to treatment in first occurrence, non-severe Clostridioides difficile infection for elderly patients: are we waiting too long to treat?

Rhett Vandervelde, Mark E Mlynarek, Mayur Ramesh

Pageof 2

Frequent Collaborators

4 joint publications

Nathaniel M Lewis

4 joint publications

Shekhar Ghamande

4 joint publications

Basmah Safdar

3 joint publications

Joseph Miller